Embed Size (px)
Citation preview
MedTech Bootcamp2018
EIT Health is fostering health-related startups to scale at European level. One highlight with this respect comprises the Bootcamp programs. These have been established throughout Europe due to strong demand in recent years.
The great success of our �rst EIT Health Bootcamp at YES!Delft (oversubscribed by 8x) with a �eldtrip to our European industry partners triggered Europe-wide interest from numerous very promising teams that we couldn't serve properly. Thus, the programme is replicated in 2018 to �ve other regions and topics, increasing the number of available spots by a factor of six by 5 new programs taking place all over Europe in Germany, Spain, Poland, Ireland and the Netherlands.
As a former director of ZiMT, I’m very proud and happy that one of those will take place in Erlangen at FAU, hosted by the Central Institute of Medical Engineering (ZiMT) in collaboration with Medical Valley, UnternehmerTUM, d.hip, Siemens and many others. The two to three month programs strengthen ambitious entrepreneurs in the HealthTech sector in the implementation of their ideas at European level.
I’m very much looking forward to the results and the winning team that will be presented at the annual EIT Health summit in December this year.
Dr. Kurt Höller, MBADirector of Business Creation, EIT Health e.V.
Greetings
It is my pleasure to welcome you to the MedTech Bootcamp. I hope you are as excited as I am to discover our 10 participating startup teams and their newest healthcare innovations. Hosted by the Central Institute of Medical Engineering (ZiMT) of the FAU and their partners Medical Valley EMN, UnternehmerTUM, the roadshow partners, the MedTech Bootcamp aims to launch new businesses capable of maintaining their market success in the European startup scene. Our mission is to provide practical assistance from dedicated coaches, healthcare professionals, and specialists in the MedTech sector. The MedTech Bootcamp is committed to supporting its entrepreneurs in designing and validating their business models, advancing their prototypes, and targeting customers. The initial 4-week training phase will be followed by 3 weeks of roadshow stops at IESE in Barcelona, YES!Delft, and NUI Galway, where the teams will pitch their ideas in front of possible investors, learn market speci�cities, and challenge their value propositions. Over the following pages, we invite you to �nd out more about our innovators and their unique products. Feel free to get in touch with them directly, and prepare yourself to be excited and inspired.
Thank you for joining us, and good luck to our teams!
Heike LeutheuserActivity Leader EIT Health Bootcamp: MedTechManaging Director of Central Institute of Medical Engineering (ZiMT), Friedrich-Alexander University Erlangen-Nuernberg (FAU)
A very warm welcome
The EIT Health MedTech Bootcamp 2018
The MedTech Bootcamp aims to e�ciently equip interdisciplinary teams of young and ambitious engineers and health practitioners with an individually tailored entrepreneurial toolbox, a convincing business plan and a strong network of investors to catapult their promising healthcare transforming ideas from sketch to market.
The 2-month program is aimed at Master students, PhD students and health practitioners as well as young engineers with a startup idea in healthcare. Throughout the program each team will transform ideas into successful startups while learning and working on business creation and validation.
MedTech Bootcamp Program
10th – 14th September | UnternehmerTUM Munich
10th Welcome, schedule and individual coaching11th Market opportunities and customer interviews12th Market evaluation and individual coaching time 13th Market focus, pitch training, and pitch event14th Individual coaching and free lab time
17th – 21st September | UnternehmerTUM Munich
17th Pitch training and Business Model Challenge18th Pitch training and team building consulting19th Maker Space Tour and networking20th Team building consulting, free lab time and o�cial conclusion
1st phase – Business Design Toolbox
1st – 5th October | ZOLLHOF and ZiMT/ d.hip
1st Welcome at FAU and introduction to medical device directive2nd Interview workshop3rd Public holiday4th Methods for Service Design and free lab time5th Medical devices in the market and individual coaching time
8th – 12th October | JOSEPHS and ZiMT/ d.hip
8th Prototyping and feedback, pitch event and networking9th WorkPlay Experience and individual coaching time10th EIT Health Catapult Digital Health Semi�nals11th Medical Device Regulation, individual coaching and lab time12th Roundup and outlook, evening event: MaD Lab Inauguration Party
2nd phase – Validation
22nd – 26th October | IESE Business School Barcelona
22nd Innovation overview and secrets of the perfect pitch23rd Language of Finance24th Entrepreneurial Finance and Inspirational Talk – Entrepreneurial Success Case25th Site visits and networking group dinner 26th Pitch training and pitch event
29th October – 1st November | YES!Delft
29th Introduction and startup talk30th Pitch training and lunch pitch session31st Free lab time1st Fieldtrip InnovationLabs TU Delft and networking2nd Free lab time
5th – 9th November | National University of Ireland, Galway
5th Welcome and introduction6th MedTech startup showcase7th Site visits and guest speakers8th Bootcamp prep time9th Final pitch event
3rd phase – Roadshow
22nd – 26th October | IESE Business School Barcelona
22nd Innovation overview and secrets of the perfect pitch23rd Language of Finance24th Entrepreneurial Finance and Inspirational Talk – Entrepreneurial Success Case25th Site visits and networking group dinner 26th Pitch training and pitch event
29th October – 1st November | YES!Delft
29th Introduction and startup talk30th Pitch training and lunch pitch session31st Free lab time1st Fieldtrip InnovationLabs TU Delft and networking2nd Free lab time
5th – 9th November | National University of Ireland, Galway
5th Welcome and introduction6th MedTech startup showcase7th Site visits and guest speakers8th Bootcamp prep time9th Final pitch event
Our Partners
EIT Health
Leading healthcare innovations to the market
Facts:
Partnership involving more than 140 health industry leaders, including pharma and medtech, universities, research, payers, healthcare providers and others
Registered association since July 2015
Headquarters in Munich, Germany
Public-Private partnership: The budget (€2 billion until 2022) is funded by the EU (25%) and the partners (75%)
EIT Health
EIT Health is one of the largest healthcare initiatives worldwide. The network of partners has the goal of supporting innovation in healthcare, in order to improve the sustainability of healthcare systems, promote healthy living and active ageing and enhance the overall wellbeing of people across Europe.EIT Health leverages the expertise of more than 140 leading organisations from key areas of healthcare, such as pharma, medtech, payers, ICT, diagnostics and consumer products, as well as some of the world’s leading academic and research organisations, healthcare providers and public administrations.Demographic change is a major challenge facing European societies today. The growth in the oldest segment of the population, and an increase in chronic diseases, is putting pressure on health and social care costs. EIT Health brings together a powerful network of partners with a clear mission: to accelerate entrepreneurship and innovation in healthy living and active ageing by providing Europe’s top talents with new oppor-tunities and resources, for the bene�t of all citizens.
Contact:Jan-Philipp Beck, CEO
Postal address:Mies-van-der-Rohe-Straße 180807 Munich
Email:[email protected]
Website: www.eithealth.eu
Central Institute of Medical Engineering (ZiMT)
We are o�ering:
Startup programs
Startup consulting and support
Knowledge of current and future projects at the FAU and other universities in Bavaria
Interface between industry, research and education
Access to a network of research experts
Access to a network of industrial partners and coordination of interdisciplinary projects
Central Institute of Medical Engineering (ZiMT)
The o�ce of the Central Institute of Medical Engineering (ZiMT) operates as an interdisciplinary communication center between the Faculties of Engineering, Medicine and Sciences regarding the topics of university education, research funding and translation for the industry and clinics. Entrepreneurship and innovation are fundamental aspects of local and global economic environments, especially in the sphere of medical technology and healthcare engineering. From this perspective, the Central Institute of Medical Engineering (ZiMT) serves companies as a key contact in the FAU community and nationwide. The Central Institute’s responsibility is to support promising ideas from our partners and tailor cooperation between industrial and research players. Together, our goal will be to establish scienti�cally innovative products, that meet real requirements of the market and to develop a strong innovative force in the Medical Valley. Our services allow for requests from entrepreneurial partners to be integrated in collaborations at the FAU and to bene�t from synergistic cooperation with relevant experts that may not directly be available or visible to the public.
Contact:Dipl.-Phys. Heike Leutheuser,Managing Director
Postal address:Henkestraße12791052 Erlangen
Email:[email protected]
Website: www.zimt.fau.eu
Friedrich-Alexander UniversityErlangen-Nürnberg
A university is privileged to something only human beings can �nd deep within themselves, an understanding of pure knowledge. Wilhelm von Humboldt
Facts:
39,780 students
265 degree programs
7436 graduates
722 doctoral degrees
57 habilitations
579 professors
Friedrich-Alexander UniversityErlangen-Nürnberg
Contact:Prof. Dr. Joachim Hornegger,President
Postal address:Schlossplatz 491054 Erlangen
Email:[email protected]
Website: www.fau.eu
FAU is one of the leading research-focused universities in Germany. We work actively to build on this position and strive to guarantee freedom in research as a prerequisite for scienti�c advancement. FAU is committed to the unity of research and education. The research we undertake is oriented towards both theory and its practical applica-tions. At FAU we are constantly developing new areas of expertise of particular signi�cance for the future of science and society. Established scienti�c and ethical standards guide our research: methods are transparent and newly gained knowledge is discussed and debated in open exchanges with the academic community and the wider public. One aim of particular importance to us at FAU is to provide researchers in the early stages of their academic careers with the highest level of support and skills. This means, above all, giving young researchers the opportunity to take on responsibility and to conduct research independently.
Medical Valley ENM e.V.
Medical Value by Medical Valley!
Facts:
500 companies active in medtech & digital health
70 hospitals + strong outpatient sector
850.000 inpatients treated per year
80 institutes at universities and universities of applied sciences focused on medtech and digital health
20 non-university research institutions in the medtech �eld
Medical Valley EMN e.V.
Medical Valley EMN is Germany’s leading edge medtech cluster and digital health hub. Medical Valley cluster management o�ers a compre-hensive service portfolio to support SME’s innovation process from the initial product idea to market maturity, thus shortening the time to market. Following the one stop shop principle, we integrate established specialists and experts within the cluster along the medical technology innovation chain. Important service components are o�ered in the areas of subsidy acquisition and consulting, identi�cation and procurement of clinical partners, market approval and reimbursement, strategic require-ment analysis and health-economic evaluation and international market access.
Contact:Jörg Trinkwalter
Postal address:Henkestraße 9191052 Erlangen
Email:[email protected]
Website: www.medical-valley-emn.de
UnternehmerTUM
Turning inventions into innovations and scalable startups
Facts:
Founded 2012
More than 150 tech-based startups a year
More than 1000 entrepreneurs per year
UnternehmerTUM
Center for Innovation and Business Creation at TU München
UnternehmerTUM o�ers founders and startups a complete service from the initial idea to IPO. A team of experienced entrepreneurs, scientists, managers and investors supports founders with the development of their products, services and business models. The experts accompany them actively with building up their companies, market entry and �nancing – also via Venture Capital.
Contact:Patrizia Pawelek
Postal address:Lichtenbergstraße 685748 Garching, Munich
Email:[email protected]
Website: www.unternehmertum.de
IESE Business School
I believe IESE
Facts:
17 professors in entrepreneurship
33% of IESE alumni create a company after graduation
1000 MBA members of the entrepreneur-ship, VC and PE clubs
5 seed funds raised
€43 million invested in 180+ startups through FINAVES and the Business Angels Network
IESE Business School
The mission of the Entrepreneurship and Innovation Center (EIC) is to foment entrepreneurship and innovation through the promotion of quality research and the development of activities that have a positive impact on the ecosystem at all stages of the entrepreneurial process. IESE´s world-class faculty enhances entrepreneurship within society and collaborates with leaders around the world to optimize innovation management. Healthcare is one of the focused industries where IESE is seeking a transformational impact through managerial capacity building and the development of applied research. In 2011, IESE created the Centre for Research in Healthcare Innovation Management (CRHIM) to support this goal, building on more than 30 years of IESE health-sector activities started in the 1980s.IESE Business School has been ranked #1 in the world for Executive Programs by Financial Times for four consecutive years since 2015.
Contact:Luca Venza
Postal address:Avenida Pearson 2108034 Barcelona
Email:[email protected]
Website: www.iese.edu
YES!Delft
Building tomorrow’s leading �rms
Facts:
Ranked 2nd business incubator worldwide
12 years experience
200+ companies
€ 400 M invested
3 years EIT Health Bootcamp partner
YES!Delft
Re-thinking our energy supply, innovating complex processes and discovering the human body. Imagine inkless printing, energy from the ocean or cutting edge laser technology. That’s YES!Delft innovation. From looking at complex DNA to discovering space with rockets. Our entrepreneurs build hardware products that impact the world of today and tomorrow.YES!Delft o�ers guidance and support to graduates, scientists, engineers and professionals in their startup journey. Our programs turn promising new technologies and teams into solid startups. We focus on customer validation and long-term growth of complex technologies. YES!Delft o�ers access to mentors, experts, investors and partners who share their know-how, network and experience. YES!Delft started in 2005 as an initiative from Delft University of Technology, the City of Delft and TNO Companies. Since then YES!Delft has grown into one of the leading tech incubators in Europe. In 2015, YES!Delft was ranked as a top incubator by University Business Index (UBI), being number 2 worldwide. YES!Delft is an EIT Health partner since 2016 and ran 3 times in a row a successful bootcamp called EIT Health Validation Lab.
Contact:Tjarda Voorneman
Postal address:Molengraa�singel 122629 JD Delft
Email:[email protected]
Websites: www.yesdelft.nl
BioExel
Facts:
Support of up to 14 SME based in the Western Region from 2017 to 2019 Mentor-centric programme, delivered by an experienced management team and a seasoned Entrepreneur-in residence to help Medtech startups to signi�cantly accelerate their technology opportunities in an intensive 6 month period
Running Fellowship programme for 8 years
Over 80 fellows trained across 15 clinical areas with 22 technologies funded by Enterprise Ireland Commercialisation Grants
Yearly series of 10 one-day workshops to work in multidisciplinary teams to progress an unmet clinical need
Medtech Accelerator BioExel at NUI Galway, is supported by Enterprise Ireland, to further enhance the medical technology sector startup ecosystem within Ireland and attract global talent to the Galway region. Other partnership sponsors are the Western Development Commission, the Galway University Foundation and the Bank of Ireland Seed and Early Stage Equity Fund. This Accelerator program is now open to applications from teams or individuals both in Ireland or international, with an opportunity in the medical technology sector.
BioInnovate Ireland is a medical technologies innovation program that employs the Biodesign model in the Irish and European ecosytem. Combining needs-led innovation and entrepreneurship in a regulated industry, the program ensures innovations emerging from it are validated clinical problems that are responding to a market pull rather than a technology push. Mid-career professionals are engaged full-time in multidisciplinary teams with the goals to identify and validate unmet clinical needs, de-risk them commercially, clearly de�ne the value proposition, and design a strategy for commercialisation and overcoming the market access barriers for medical devices. Fellows have unparalleled access to and receive mentorship from industry experts, leaders, entrepreneurs, investors and clinicians. The program is cofunded by Enterprise Ireland. It is a national program with collaboration with all HEIs and is led from NUI Galway.
Contact:Sandra Ganly
Postal address:BLE 1002, Block ENational University of IrelandUniversity Road, Galway
Email:[email protected]: www.bioexel.ie
Contact:Paul Anglim Ena Brophy
Postal address:Block E, National University of Ireland University Road, Galway
Email:[email protected] Website: www.bioinnovate.ie
Our Teams
PSYON
Deepsense
Looking for:
We are looking for funding and partnerships with hospitals.
Deepsense
Deepsense is a cardiac and respiratory monitoring device that allows a follow-up of babies without electrodes, eliminating the risks of lesions and irritations. At Deepense, we use technologies of nanosensors and machine learning algorithms to improve the lives of preterm babies, parents and caregivers and allow follow-up even for the youngest, whose most fragile skin does not support any electrode.What we do: Deepsense is a medical pad to put under the mattress, that allows extremely precise tracking of the baby’s heart and respiratory rates. Our innovation is life changing for :- Patients : preterm and extreme preterm babies su�er from the stress of all the actual intrusive devices and it can lead to lofe-long scars- Nurse and Doctors : nurses are eager to have a device that is easier to handle that can be removed without any problems for the patient - Parents : Stressed by the situation of their child and the vision of all the monitoring devices
Contact:Yassine Mountacif
Email:[email protected]
Website: www.thedeepsense.co
DermaScreen
Looking for:
We are looking for a seed-investor with experience in distribution of medical-grade software and a network in the dermatology community.
DermaScreen
DermaScreen has developed an AI-powered algorithm that can detect melanoma with higher diagnostic accuracy than experienced dermatologists. We are preparing to make the algorithm available to dermatologists and GPs as a medically approved diagnostic decision support software. The software allows practitioners to earlier detect melanoma, while also reducing the number of unnecessary biopsies. In comparison to existing solutions, our o�ering comes with 4 main advantages: (a) higher diagnostic accuracy compared to tools available on the market, (b) no upfront investment / hardware lock-in of customers, (c) unmatched speed of diagnosis (c.8 seconds computing time) and (d) does not require additional hardware Dermatologists and GPs will be charged annual license fees to get access to our software. Physicians can but do not have to charge private patients or patients paying out of pocket for the usage of the algorithm. DermaScreen is funded by Germany's Federal Ministry for Economic A�airs and Energy (BMWi) and the European Social Fund (ESF) through the EXIST Business Start-up Grant.
Contact:Dominik Seliger Christian Ludwigs
EMBIO Diagnostics Ltd
Looking for:
We are looking to identify interested companies and investment �rms that will assist us with improving the technology so that it is usable and complies with the Medical Device Regulation.
Priority is to match the needs of the industry with what we o�er.
EMBIO Diagnostics Ltd
EMBIO Diagnostics aims to improve the quality of life and reduce the everyday stress for people. Our goal is to create a device that monitors speci�c health biomarkers that are connected to speci�c diseases. The device will be user friendly and the end-user will have the opportuni-ty to use it independently or with the assistance of another person. It will be connected with their personal doctor so they could see the analytic health condition the moment the measurement is done. The target groups will be active users who will monitor biomarkers, vital for their health, anywhere and whenever they like; and medical clinics, hospitals, private doctors and pharmaceutical companies, all acting to support the end-users. The device will be used after a short training, and the end-users will have to prick their �nger to get a small amount of blood and analyze it immediately (within 3 minutes) using our unique technology.
Contact:Constantinos Loizou Katerina Loizou Antonios Inglezakis
Email:[email protected]@[email protected]
Website: www.embiodiagnostics.eu
EXAL BONE
The innovative personalized orthopedic casting
Looking for:
Alliances with industry entities in the �elds of distribution, production or distribution licenses.
Contacts to representatives of the M&A divisions of medical equipment manufacturers (e.g. 3M).
Contacts to KOL on European/American markets and institutions to develop strategies to enter the European market (to develop schemes of the "reimburse-ment process" by national insurers).
EXAL BONE
Exal Bone - the innovative personalized orthopedic casting for bone fractures, dislocations and injuries, that will change the future of orthope-dics and rehabilitation. Exal Bone is a medical device combining the therapeutic and functional advantages of previously used plaster dressings and synthetic plaster. It is made of biodegradable and hypoal-lergenic material ensuring complete safety, which allows shortening the implementation path to clinical practice. The technology is covered with patent protection.Unique features of Exal Bone:- light, waterproof dressing replacing gypsum, stronger than plaster- openwork construction, allowing ventilation of the skin surface, not causing irritation or pruritus- can be discreetly worn under clothingThe most important feature - it allows the adjustment of the shape of the dressing to the clinical needs of the patient without unnecessary haste and fear of premature solidifying of the dressing. Possible re-modeling of the dressing, in case of swelling of the broken limb. Eliminates the situation of improper formation of the dressing, which may cause inconvenience, i.e. health risks resulting from limb ischemia.
Contact:Mateusz Siwak, CEO
Email:[email protected]
Website: www.exalbone.eu
Niucare
Exal Bone - the innovative personalized orthopedic casting for bone fractures, dislocations and injuries, that will change the future of orthope-dics and rehabilitation. Exal Bone is a medical device combining the therapeutic and functional advantages of previously used plaster dressings and synthetic plaster. It is made of biodegradable and hypoal-lergenic material ensuring complete safety, which allows shortening the implementation path to clinical practice. The technology is covered with patent protection.Unique features of Exal Bone:- light, waterproof dressing replacing gypsum, stronger than plaster- openwork construction, allowing ventilation of the skin surface, not causing irritation or pruritus- can be discreetly worn under clothingThe most important feature - it allows the adjustment of the shape of the dressing to the clinical needs of the patient without unnecessary haste and fear of premature solidifying of the dressing. Possible re-modeling of the dressing, in case of swelling of the broken limb. Eliminates the situation of improper formation of the dressing, which may cause inconvenience, i.e. health risks resulting from limb ischemia.
Looking for:
MedTech companies for joint use cases & pilots
Healthcare providers, planning to make use of patient-centered solutions
Business angels and seed investors with MedTech / healthcare back-ground / SaaS a�nity
Niucare
Niucare helps medical companies and healthcare providers in building a better tomorrow. Our technology gives them the right tools and a secure environment to create digital, smart and patient-focused services. Connecting the right dots for seamless exchange of patient information and medical data is our main job. Because better health solutions, available information and shared knowledge is the best way to make patients’ lives better and help doctors in their daily work.Our platform is designed to apply the latest technology for protected data exchange between patient apps, medical devices, digital health services and wearables to manage and align healthcare sensitive information. We are the �rst open API of its kind in Europe, in particular regarding the General Data Privacy Regulations and EU patient data privacy.From single API modules to full cloud-applied data processing for one to one million patients: Don’t start building digital health-tech infrastructure, when you can directly start providing healthcare services.
Contact:Laurent Schüller
Email:[email protected]
Website: www.niucare.com
Openwrist
Looking for:
Improving the business model of our project
Knowing the European health care market better
Knowing how to get investment for clinical trials
Expanding our networking
Becoming familiar with similar projects to build alliances
Openwrist
There are more than 5 million upper limb amputees in the world. The current solutions on the market lack a fundamental feature, which is the wrist rotation. Without it, any simple task with the prosthesis become a challenge to the user and could even imply long-term harm for the user’s shoulder articulation.Openwrist is an arti�cial wrist which adds rotation functionality to any kind of upper limb prosthesis. The user will be able to control the rotation of his/ her prosthesis by doing little inclination movements of the head. It will be modular and easy to connect to the di�erent upper limb prosthe-sis currently available on the market. Even though our technology is state of the art in the prosthesis domain, the components used and the manufacturing procedure makes Openwrist not only intuitive and comfortable but also a�ordable.
Contact:Jesus MagoSihem Gourou
Email:[email protected]@[email protected]
Website: www.facebook.com/OpenWrist
OPSYON
Fusing tumor targeting and immunecheckpoint blockade
Looking for:
Network: OPSYON is looking for collaboration partners to complete preclinical studies.
Consulting: OPSYON requires advice concerning business plan writing, �nancing, business development and patent applications.
Investments: To expand our portfolio and substantiate our patent application, we would need a �nancial investment of 3-5 Mio. € in the next three years.
OPSYON
There is a strong rationale and emerging trend to use immune checkpoint inhibitors in combination with other cancer therapies to enhance immune response against tumors. However, due to treatment-related adverse events, the value of combination therapy remains controversial. OPSYON generates new and e�ective immuno-oncology therapeutics with reduced systemic toxicities. Our technology con�nes the bene�ts of immune checkpoint inhibition to tumor cells, thus providing cancer patients a long-term possibility for progression-free survival and low risk of side e�ects. Our antibody-based therapeutics bring tumor and immune cells in close vicinity by speci�cally targeting tumor cells with high a�nity and restore the activity of immune cells with a low a�nity blockade of immune checkpoint receptors. Our lead candidate focuses on the emerging innate immune checkpoint CD47 in the target indication acute myeloid leukemia (AML). AML is an aggressive disease with limited numbers of therapeutic agents, highlight-ing the need for innovative therapies. Besides, AML provides the basis for quick success for an orphan drug to reach market approval. Currently, we transfer OPSYON’s technology to solid cancers.
Contact:Dr. Laia Pascual Ponce,Dr. Nadja Fenn
Email:[email protected]@genzentrum.lmu.de
Website: www.opsyon.de
PSYON
ReMeDi – Remote Medical Diagnostician
Looking for:
Funds for completing the system for certi�cation
Perform the system certi�cation
Cooperation with a manufacturer of ultrasonographic scanners
Pilot customers also wishing to test the system before certi�cation
ReMeDi – Remote Medical Diagnostician
ReMeDi addresses the problem of unequal geographic distribution of medical doctors between rural and urban areas. It is a system for real-time ultrasonographic examinations. First, a semi-autonomous device will enable doctors to perform diagnostics remotely, without being physically present at the point of care. Further, the robotic system will autonomously examine patients and provide diagnoses. The ReMeDi system consists of an anthropomorphic robot operating in a remote hospital and a control interface placed at the doctor’s location that are connected via a cloud-based connection platform on a subscription basis. ReMeDi goes beyond classical telepresence concepts: It captures and processes multi-sensory data (integrating visual, haptic, speech, patient’s physiological responses) into perception and reasoning capabilities, making ReMeDi a diagnostic assistant o�ering context-dependent and proactive support for the doctor. ReMeDi is able to perform all types of surface ultrasonography. Additionally, the intuitive and very convenient control of ReMeDi with force-feedback is closest to direct ultrasonography and is generally accepted by patients and doctors.
Contact:Borys Chibisov
Email:[email protected]
Website: www.remedi-project.eu
Theraselect
Looking for:
We are looking for motivated people and solutions supporting our vision to �nd e�ective drugs for cancer treatment and to develop new tests to achieve higher treatment success through personalized treatment of each individual patient.
Theraselect
The project Theraselect aims to create new diagnostic and pharmacologi-cal tests to improve treatment for cancer patients. The basis for the spin-o� from the Department of Analytical Pathology at the Helmholtz Zentrum München is specially developed methods in mass spectrometry imaging that make thousands of molecules visible in tissue samples. In addition to the cell structure, this makes it possible to see which molecules are present at which location in a kind of molecular map. This can help drug studies to di�erentiate between active ingredients and their metabolic products in order to verify the success of a treatment. The method also allows speci�c biomarker pro�les to be collected from clinical tissue samples. Based on the results, doctors would be able to make personalized treatment decisions in the future. The site-speci�c detection of previously undetectable, treatment-relevant molecules can set new standards in diagnostics.
Contact:Dr. Achim Buck
Email:[email protected]
Vooiage TechnologiesMaking every physiotherapy session extraordinary
Looking for:
We are looking to strengthen our network in Europe, develop new partners and have access to funding which can support us in achieving our key milestones and catapult our growth.
Vooiage Technologies
Vooiage is a MedTech start-up based in Madrid. Our mission is to create innovative healthcare solutions using cutting edge technologies combined with data analytics to improve the experience of both professionals and patients around the world. Our �rst product VooiageFisio© is an all-in-one virtual reality application for physiotherapists to manage patient recovery e�ciently and increase their motivation. The product features: - Immersive & entertaining therapy - Interactive gami�ed VR modules- Data analytics to evaluate progressVooiageFisio© aims to provide a better experience to the physio-therapists, patients and their family members by creating a more engaging physiotherapy while enabling quanti�¬able data capture for improvement tracking.
Contact:Ana Carolina Guglielmi
Phone:+34 693700436
Email:[email protected]
Website: www.vooiage.com
EIT Health Achievements in 2017As a network of best-in-class health innovators in Europe, EIT Health addresses the challenges of today’s health and healthcare in Europe. In 2017, we made further progress in building and implementing the portfolio of activities that it takes to tackle the grand challenges we address.
